4 DISCUSSION The burgeoning number of cancer survivors has led to an increasing trend of developing a second cancer, which has posed challenges for clinical decisions and oncological practices. 13 Few studies have focused on survivors since they were commonly excluded from cohort enrollment in clinical trials. 14 Similar trends were also found in gastric cancer trials, 6 , 9 in which individuals with a history of malignancy were excluded from the eligible population.
1
—
—